Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Investigation of sorafenib tosylate loaded liposomal dry powder inhaler for the treatment of non-small cell lung cancer
Khushboo Patel, C. Bothiraja, Ashwin Mali, et al.
Particulate Science And Technology (2021) Vol. 39, Iss. 8, pp. 990-999
Closed Access | Times Cited: 16

Showing 16 citing articles:

Lipid Nanocarrier-Based Drug Delivery Systems: Therapeutic Advances in the Treatment of Lung Cancer
Sojung Kim, Nidhi Puranik, Dhananjay Yadav, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 2659-2676
Open Access | Times Cited: 34
Recent advances in liposome-based targeted cancer therapy
Yeliz Fidan, Stela Muçaj, Selin Seda Timur, et al.
Journal of Liposome Research (2023) Vol. 34, Iss. 2, pp. 316-334
Closed Access | Times Cited: 26
Formulation strategies for bacteriophages to target intracellular bacterial pathogens
Wei Yan, Parikshit Banerjee, Miao Xu, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113864-113864
Closed Access | Times Cited: 44
Pulmonary Delivery of Anticancer Drugs via Lipid-Based Nanocarriers for the Treatment of Lung Cancer: An Update
Ibrahim M. Abdulbaqi, Reem Abou Assi, Anan Yaghmur, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 8, pp. 725-725
Open Access | Times Cited: 44
Sorafenib-Based Drug Delivery Systems: Applications and Perspectives
Lingyun Wang, Meihuan Chen, Xueguang Ran, et al.
Polymers (2023) Vol. 15, Iss. 12, pp. 2638-2638
Open Access | Times Cited: 14
Efficacy of Sorafenib-Based Therapies for Non-Small Cell Lung Cancer
Morgann Hendrixson, Yevgeniy Gladkiy, Anita Thyagarajan, et al.
Medical Sciences (2024) Vol. 12, Iss. 2, pp. 20-20
Open Access | Times Cited: 4
A nanotechnology driven effectual localized lung cancer targeting approaches using tyrosine kinases inhibitors: Recent progress, preclinical assessment, challenges, and future perspectives
Ankaj Kumar, Klaudi K. Vaiphei, Arvind Gulbake
International Journal of Pharmaceutics (2024), pp. 124745-124745
Closed Access | Times Cited: 4
Sorafenib tosylate novel drug delivery systems: Implications of nanotechnology in both approved and unapproved indications
Hrushikesh C. Raut, Chetana Jadhav, Karishma Shetty, et al.
OpenNano (2022) Vol. 8, pp. 100103-100103
Open Access | Times Cited: 18
Quality by Design in Pulmonary Drug Delivery: A Review on Dry Powder Inhaler Development, Nanotherapy Approaches, and Regulatory Considerations
Ashish Dilip Sutar, Rahul Kumar Verma, Rahul Shukla
AAPS PharmSciTech (2024) Vol. 25, Iss. 6
Closed Access | Times Cited: 3
Hydrothermal Synthesis and Characterization of Hollow Mesospherical Alumina Nanoconstructs for Enhanced Delivery of Sorafenib Tosylate
Nishant Chopade, Mahesh P. More, Sagar R. Pardeshi, et al.
BioNanoScience (2025) Vol. 15, Iss. 2
Closed Access
“Nano-in-Micro” Structured Dry Powder Inhalers for pulmonary delivery: Advances and challenges
Jinxue Cao, Yuyi Xu, Jian Zhang, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 96, pp. 105648-105648
Closed Access | Times Cited: 3
Inhaled Medicines for Targeting Non-Small Cell Lung Cancer
Arwa Omar Al Khatib, Mohamed El‐Tanani, Hisham Al-Obaidi
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2777-2777
Open Access | Times Cited: 7
Insights into Lipid-Based Delivery Nanosystems of Protein-Tyrosine Kinase Inhibitors for Cancer Therapy
Josef Jampílek, Katarína Kráĺová
Pharmaceutics (2022) Vol. 14, Iss. 12, pp. 2706-2706
Open Access | Times Cited: 9
In vitro cytotoxicity of magnetic-fluorescent bioactive glasses on SaOS-2, MC3T3-E1, BJ fibroblast cells, their hemolytic activity, and sorafenib release behavior
Aylin M. Deliormanlı, Begüm Rahman, Harika Atmaca
Biomaterials Advances (2024) Vol. 158, pp. 213782-213782
Closed Access | Times Cited: 1
Ultrasound-Mediated In Vivo Biodistribution of Coumarin-Labeled Sorafenib-Loaded Liposome-Based Nanotheranostic System
Usama Sarwar, Muhammad Naeem, Farwa Nurjis, et al.
Nanomedicine (2022) Vol. 17, Iss. 25, pp. 1909-1927
Closed Access | Times Cited: 5
Formulation and characterization of mometasone furoate and formoterol fumarate containing dry powder inhaler by spray drying and homogenization methods
Yagmur Akdağ, Tugba GULSUN, Nihan IZAT, et al.
Journal of Research in Pharmacy (2022) Vol. 26 (2), Iss. 26 (2), pp. 383-396
Open Access | Times Cited: 3
Page 1

Scroll to top